help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Published ahead of print on April 28, 2005, doi:10.1164/rccm.200403-387OC
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
200403-387OCv1
172/2/212    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Boyle, M. P.
Right arrow Articles by Lechtzin, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Boyle, M. P.
Right arrow Articles by Lechtzin, N.
American Journal of Respiratory and Critical Care Medicine Vol 172. pp. 212-217, (2005)
© 2005 American Thoracic Society
doi: 10.1164/rccm.200403-387OC

Original Article

Failure of High-Dose Ergocalciferol to Correct Vitamin D Deficiency in Adults with Cystic Fibrosis

Michael P. Boyle, Michelle L. Noschese, Sharon L. Watts, Marsha E. Davis, Shane E. Stenner and Noah Lechtzin

Johns Hopkins Adult Cystic Fibrosis Program, Johns Hopkins Division of Pulmonary and Critical Medicine, Baltimore, Maryland

Correspondence and requests for reprints should be addressed to Michael P. Boyle, M.D., Johns Hopkins Adult CF Program, 1830 East Monument Street, 5th floor, Baltimore, MD 21205. E-mail: mboyle{at}jhmi.edu

Rationale: Treatment guidelines for vitamin D monitoring and supplementation in cystic fibrosis (CF) have recently been developed and published by a consensus committee, but have not been prospectively tested. Objectives: To use these guidelines to determine the percentage of adults with CF requiring vitamin D repletion therapy and to evaluate the effectiveness of the currently recommended high-dose oral ergocalciferol repletion protocol. Methods: Prospective study of clinical outcomes after therapy with the recommended vitamin D repletion algorithm. Results: Of 134 adults with CF, 109 (81.3%) were found to have 25-hydroxyvitamin D (25-OHD) levels below the recommended 30 ng/ml. Sixty-six of these adults completed the recommended course of 400,000 IU of oral ergocalciferol over 2 months, and only five (8%) responded with correction of their serum 25-OHD to the goal of 30 ng/ml or greater (mean change, +0.3 ng/ml; from 18.8 to 19.1 ng/ml). In the 33 adults with CF who also completed the recommended second course of 800,000 IU of ergocalciferol over 2 months, none demonstrated correction of their deficiency (mean change, –1.2 ng/ml). Conclusion: The results of this study demonstrate that a majority of adults with CF have serum 25-OHD levels below 30 ng/ml, and the currently recommended ergocalciferol repletion regimen often does not fully correct vitamin D deficiency and may need to be revised to include even higher dosing of ergocalciferol. Further work is needed to establish the ideal 25-OHD level for maximizing calcium absorption and bone health in CF.

Key Words: bone growth • dietary supplements • 25-hydroxyvitamin D • osteoporosis




This article has been cited by other articles:


Home page
 J. Clin. Endocrinol. Metab.Home page
N. B. Khazai, S. E. Judd, L. Jeng, L. L. Wolfenden, A. Stecenko, T. R. Ziegler, and V. Tangpricha
Treatment and Prevention of Vitamin D Insufficiency in Cystic Fibrosis Patients: Comparative Efficacy of Ergocalciferol, Cholecalciferol, and UV Light
J. Clin. Endocrinol. Metab., June 1, 2009; 94(6): 2037 - 2043.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
A. W Norman
From vitamin D to hormone D: fundamentals of the vitamin D endocrine system essential for good health
Am. J. Clinical Nutrition, August 1, 2008; 88(2): 491S - 499S.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
E. Robberecht and S. Vandewalle
Cholecalciferol and 25-hydroxyvitamin D concentrations in adults with cystic fibrosis
Am. J. Clinical Nutrition, January 1, 2008; 87(1): 190 - 190.
[Full Text] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
A. Stephenson
Reply to E Robberecht and S Vandewalle
Am. J. Clinical Nutrition, January 1, 2008; 87(1): 190 - 191.
[Full Text] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
A. J Rovner, V. A Stallings, J. I Schall, M. B Leonard, and B. S Zemel
Vitamin D insufficiency in children, adolescents, and young adults with cystic fibrosis despite routine oral supplementation
Am. J. Clinical Nutrition, December 1, 2007; 86(6): 1694 - 1699.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
A. Stephenson, M. Brotherwood, R. Robert, E. Atenafu, M. Corey, and E. Tullis
Cholecalciferol significantly increases 25-hydroxyvitamin D concentrations in adults with cystic fibrosis
Am. J. Clinical Nutrition, May 1, 2007; 85(5): 1307 - 1311.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
F. J. Accurso
Update in cystic fibrosis 2005.
Am. J. Respir. Crit. Care Med., May 1, 2006; 173(9): 944 - 947.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2005 American Thoracic Society 		  ATS Par News